Keurig Dr Pepper (KDP – Research Report), the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Kaumil Gajrawala from Jefferies maintained a Buy rating on the stock and has a $41.00 price target.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Kaumil Gajrawala has given his Buy rating due to a combination of factors influencing Keurig Dr Pepper’s performance. The company is maintaining strong momentum in its U.S. beverage segment, and its international operations are showing robust growth. Coffee pricing is also on the rise, which could benefit the company in the long term.
Additionally, the recent changes in related party ownership have alleviated some pressure on shares, and the company’s free cash flow profile is expected to improve as supply chain financing impacts lessen. Furthermore, Keurig Dr Pepper’s investment in Athletic Brewing and a lower effective tax rate contribute positively to its financial outlook. These elements, combined with a steady beverage business and strategic partnerships, support the Buy rating with a price target of $41.
In another report released on April 28, Barclays also maintained a Buy rating on the stock with a $38.00 price target.